Camden National Corporation
NASDAQ:CACBanks - Regional
+$0.02 today
- Market cap
- $981.28M
- Beta
- 0.56
- P/E (TTM)
- 10.9
- EPS (TTM)
- $4.70
- Dividend yield
- 3.27%
Volume 0.06M
Average 0.10M
CAC Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Camden National CorporationNASDAQ: CAC
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization dips below year-ago levels
Q1 FY2026 depreciation & amortization of $2.62M fell 12.3% year over year, behind the +82.0% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 1.4% from the prior quarter. Over 3 fiscal years it compounded at +39.2% a year.
Context
- Depreciation & amortization amounted to 3.0% of revenue in FY2025, up 1.7 pp from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -12.3% toward the trailing-twelve-month pace of +82.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 11.1M USD
- Year-over-year change
- +187.1%
- 4-year CAGR
- +26.3%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 11.1M | +187.1% |
| FY2024 | 2024-12-31 | 3.87M | -2.4% |
| FY2023 | 2023-12-31 | 3.96M | -3.7% |
| FY2022 | 2022-12-31 | 4.12M | -5.7% |
| FY2021 | 2021-12-31 | 4.36M | — |
Depreciation & Amortization vs competitors
How CAC compares with its peers on the latest reported figures
- CAC's LTM Mar 2026 depreciation & amortization of $10.74M is the 2nd largest of the 11 companies compared; the peer median is $2.43M.
- Its year-over-year change of +82.0% is the 2nd highest of 11, against a peer median of -6.8%.
- Depreciation & amortization amounts to 3.0% of revenue for CAC, versus a peer median of 1.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $12.49M | +46.8% | +18.4% | 2.9% | |
| LTM Mar 2026 | $10.74M | +82.0% | +39.2% | 3.0% | |
| LTM Mar 2026 | $6.1M | +64.2% | +27.8% | 3.1% | |
| LTM Mar 2026 | $5.62M | -25.8% | -1.0% | 2.0% | |
| LTM Mar 2026 | $4.57M | +47.5% | +44.0% | 3.9% | |
| LTM Mar 2026 | $2.5M | +12.1% | -0.4% | 1.5% | |
| LTM Mar 2026 | $2.36M | +85.2% | +52.3% | 2.7% | |
| LTM Mar 2026 | $1.04M | -378.8% | — | 0.5% | |
| LTM Mar 2026 | $583K | -86.2% | -7.8% | 0.7% | |
| LTM Mar 2026 | $384K | -38.7% | -37.6% | 0.3% | |
| LTM Mar 2026 | $136K | -102.9% | -0.8% | 0.0% | |
| Peer median (excluding CAC) | $2.43M | -6.8% | -0.4% | 1.8% | |
Competitors are the stored peer set for CAC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 69.01M | 61.44M | 43.38M | 53M | 65.16M |
| Depreciation & Amortization | 4.36M | 4.12M | 3.96M | 3.87M | 11.1M |
| Deferred Income Tax | (637K) | 1.79M | 1.31M | 298K | 616K |
| Stock-Based Compensation | 2.38M | 2.55M | 2.79M | 2.9M | 3.42M |
| Change in Working Capital | 3.29M | (4.69M) | 6.38M | 349K | (15.78M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 3.29M | (4.69M) | 6.38M | 349K | (15.78M) |
| Other Non-Cash Items | 64.31M | 39.98M | 9.68M | 514K | (604K) |
| Operating Cash Flow | 142.72M | 105.18M | 67.51M | 60.93M | 63.91M |
| Capital Expenditures | (1.85M) | (2.18M) | (2.62M) | (5.58M) | (5.71M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 48.26M |
| Purchases of Investments | (758.85M) | (138.17M) | (137.13M) | (60.39M) | (240.46M) |
| Sales of Investments | 321.63M | 233.67M | 225.13M | 123.06M | 209.09M |
| Other Investing Activities | (210.02M) | (581.04M) | (92.41M) | (26.76M) | (67.6M) |
| Investing Cash Flow | (649.09M) | (487.72M) | (7.03M) | 30.33M | (56.41M) |
| Debt Repayment | 9.02M | 53.41M | 220.26M | 14.73M | (28.68M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | (537K) |
| Common Stock Repurchased | (10.09M) | (10.24M) | (2M) | (1.61M) | 0 |
| Dividends Paid | (21.08M) | (23.51M) | (24.54M) | (24.56M) | (28.47M) |
| Other Financing Activities | 603.38M | 217.69M | (229.83M) | 35.34M | (67.29M) |
| Financing Cash Flow | 581.23M | 237.34M | (36.1M) | 23.9M | (124.97M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 74.85M | (145.2M) | 24.38M | 115.16M | (117.47M) |
| Free Cash Flow | 140.86M | 103M | 64.89M | 55.36M | 58.2M |
Camden National Corporation
NASDAQ:CAC
Intrinsic Alpha fair value
Locked
Current Price
$58.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.